Kay Schreiter
Kay Schreiter publishes mostly in Molecular Biology, Pharmacology and Oncology, on topics such as Angiogenesis and VEGF in Cancer, Pharmacogenetics and Drug Metabolism and Retinal Diseases and Treatments.
- World rank
- #5,703,169 of 7,710,434 ranked researchers
- Rank in Germany
- #293,371 of 364,343
- Works
- 21
- Citations
- 380
- Citations per work
- 18.1
What does Kay Schreiter research?
Kay Schreiter's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (16%), Pharmacology, Toxicology and Pharmaceutics (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1047.2%
- Life Sciences836.9%
- Health Sciences315.9%
- Medicine315.9%
- 1Molecular Biology25% of their works
- 2Pharmacology7% of their works
- 3Oncology5% of their works
- 4Cell Biology5% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Ophthalmology5% of their works
Research topics
Which keywords describe Kay Schreiter's research?
The keywords of their largest research topics: Cancer Therapy, Vascular Endothelial Growth Factor, Oncogenic Mutations, Cytochrome P450, endothelial progenitor cells, Macular Degeneration, Pharmacogenetics and Retinal Pigment Epithelium.
- Ras Signaling
- Muscle Regeneration
- MAP Kinase
- Cell Division
- ANGPTL3
- VEGF
- Pharmacogenetics
- Cytochrome P450
- Vascular Endothelial Growth Factor
- Cancer Therapy
- Oncogenic Mutations
- Macular Degeneration
- Retinal Pigment Epithelium
- endothelial progenitor cells
- BRAF gene
- Lipoprotein Lipase
- Microtubules
- Protein Kinases
- Skeletal Muscle Atrophy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Cancer Therapy63 topics
- Vascular Endothelial Growth Factor62 topics
- Oncogenic Mutations42 topics
- Cytochrome P45031 topic
- Macular Degeneration31 topic
- Pharmacogenetics31 topic
- Retinal Pigment Epithelium31 topic
- VEGF31 topic
- endothelial progenitor cells31 topic
- ANGPTL321 topic
- BRAF gene21 topic
- Cell Division21 topic
- Lipoprotein Lipase21 topic
- MAP Kinase21 topic
- Microtubules21 topic
- Muscle Regeneration21 topic
- Protein Kinases21 topic
- Ras Signaling21 topic
- Skeletal Muscle Atrophy21 topic
Where does Kay Schreiter work?
Kay Schreiter's main affiliation in the publication record is Evotec (Germany), Germany.
How many publications and citations does Kay Schreiter have?
OpenAlex counts 21 works and 380 citations for Kay Schreiter, an h-index of 11, ranking #5,703,169 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Kay Schreiter. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.